Note: Ingredients listed on restricted chemical lists
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
38-<39%
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
1-<5%
General Information
Version
3 (Replaced 2
Revision date
2020-12-17
Product name
LATAPOXY 300 ADHESIVE Part.C 24-0300-0001-2C
1.2.1 Relevant identified uses
Adhesive for construction. For professional users only
1.2.2. Uses advised against
All uses not specified in this section or in section 7.3
Emergency telephone
(+39) 059 557680
Icons in SDS
Company Information
company name
LATICRETE EUROPE SRL
e-mail address of the competent person responsible for the Safety Data Sheet
info@laticreteeurope.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H335, H350, H372
Hazard statements
Code
Statements
H335
May cause respiratory irritation
H350
May cause cancer
H372
Causes damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Hazard statements
Carc. 1A: H350 - May cause cancer. STOT RE 1: H372 - Causes damage to organs through prolonged or repeated exposure (Inhalation). STOT SE 3: H335 - May cause respiratory irritation.
Precautionary statements
P201: Obtain special instructions before use. P271: Use only outdoors or in a well-ventilated area. P304+P340 IF INHALED Remove person to fresh air and keep comfortable for breathing P308+P313 IF exposed or concerned Get medical advice/attention P403+P233: Store in a well-ventilated place. Keep container tightly closed. P501: Dispose of contents/container in accordance with regulations on hazardous waste or packaging and packaging waste respectively.
Supplemental label elements
EUH212: Warning! Hazardous respirable dust may be formed when used. Do not breathe dust.
Hazardous Ingredients
Quartz (RCS > 10%); Titanium dioxide (aerodynamic diameter ≤ 10 μm)
Additional information
Restricted to professional users
2.3 Other hazards
Product fails to meet PBT/vPvB criteria Endocrine-disrupting properties: The product fails to meet the criteria.
